Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

Clinical Pharmacology: Advances and Applications Volume 13, 2021 - Issue

Submit an article Journal homepage

Open access

152

Views

CrossRef citations to date

Altmetric

Review

Novel Approaches to Treating Relapsed and Refractory Multiple Myeloma with a Focus on Recent Approvals of Belantamab Mafodotin and Selinexor

Nisha S Joseph1 Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA

Yu-Tzu Tai2 Dana-Farber Cancer Institute, Harvard University, Boston, MA, USA

https://orcid.org/0000-0001-6199-3569

Kenneth C Anderson2 Dana-Farber Cancer Institute, Harvard University, Boston, MA, USACorrespondence[email protected]

Sagar Lonial1 Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA, USA

Pages 169-180 | Published online: 18 Aug 2021

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Weijia Wu, Shuyi Ding, Zhang Mingming, Zhou Yuping, Xueshan Sun, Zixuan Zhao, Yi Yang, Yongxian Hu & Hengjin Dong. (2023) Cost effectiveness analysis of CAR-T cell therapy for patients with relapsed/refractory multiple myeloma in China. Journal of Medical Economics 26:1, pages 701-709.
Read now

Dickran Kazandjian, Andrew Kowalski & Ola Landgren. (2022) T cell redirecting bispecific antibodies for multiple myeloma: emerging therapeutic strategies in a changing treatment landscape. Leukemia & Lymphoma 63:13, pages 3032-3043.
Read now

Articles from other publishers (2)

Zaki Al‐Yafeai, Mohamed Ghoweba, Anil Ananthaneni, Hamzah Abduljabar & David Aziz. (2022) Cardiovascular complications of modern multiple myeloma therapy: A pharmacovigilance study. British Journal of Clinical Pharmacology 89:2, pages 641-648.
Crossref

Robert J. Kreitman & Ira Pastan. (2021) Immunotoxins: From Design to Clinical Application. Biomolecules 11:11, pages 1696.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references